 "Kiran Mazumdar-Shaw")
Kiran Mazumdar-Shaw, chairman and managing director of Biocon has called on the Centre to be careful in controlling prices of drugs and equipment saying that this could potentially impact the quality of healthcare in India.
"I think there is an affordability price-point which people need to understand and that is the debate we are not having. Just by forcing pricing on hospital services and drugs, what is happening today? There is a drug shortage and poor quality drugs are being offered. If you want cheap (more price control) you will devalue the entire healthcare system in India. I think the
